Literature DB >> 16731918

Recovery of avian metapneumovirus subgroup C from cDNA: cross-recognition of avian and human metapneumovirus support proteins.

Dhanasekaran Govindarajan1, Ursula J Buchholz, Siba K Samal.   

Abstract

Avian metapneumovirus (AMPV) causes an acute respiratory disease in turkeys and is associated with "swollen head syndrome" in chickens, contributing to significant economic losses for the U.S. poultry industry. With a long-term goal of developing a better vaccine for controlling AMPV in the United States, we established a reverse genetics system to produce infectious AMPV of subgroup C entirely from cDNA. A cDNA clone encoding the entire 14,150-nucleotide genome of AMPV subgroup C strain Colorado (AMPV/CO) was generated by assembling five cDNA fragments between the T7 RNA polymerase promoter and the autocatalytic hepatitis delta virus ribozyme of a transcription plasmid, pBR 322. Transfection of this plasmid, along with the expression plasmids encoding the N, P, M2-1, and L proteins of AMPV/CO, into cells stably expressing T7 RNA polymerase resulted in the recovery of infectious AMPV/CO. Characterization of the recombinant AMPV/CO showed that its growth properties in tissue culture were similar to those of the parental virus. The potential of AMPV/CO to serve as a viral vector was also assessed by generating another recombinant virus, rAMPV/CO-GFP, that expressed the enhanced green fluorescent protein (GFP) as a foreign protein. Interestingly, GFP-expressing AMPV and GFP-expressing human metapneumovirus (HMPV) could be recovered using the support plasmids of either virus, denoting that the genome promoters are conserved between the two metapneumoviruses and can be cross-recognized by the polymerase complex proteins of either virus. These results indicate a close functional relationship between AMPV/CO and HMPV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731918      PMCID: PMC1472575          DOI: 10.1128/JVI.00138-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics.

Authors:  P L Collins; S S Whitehead; A Bukreyev; R Fearns; M N Teng; K Juhasz; R M Chanock; B R Murphy
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

2.  Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation.

Authors:  S Krishnamurthy; Z Huang; S K Samal
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

3.  Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo.

Authors:  Quynh N Pham; Stéphane Biacchesi; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Analysis of the genomic sequence of a human metapneumovirus.

Authors:  Bernadette G van den Hoogen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Virology       Date:  2002-03-30       Impact factor: 3.616

5.  Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.

Authors:  A C Schmidt; J M McAuliffe; B R Murphy; P L Collins
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Rescue of a bovine respiratory syncytial virus genomic RNA analog by bovine, human and ovine respiratory syncytial viruses confirms the "functional integrity" and "cross-recognition" of BRSV cis-acting elements by HRSV and ORSV.

Authors:  A S Yunus; S Krishnamurthy; M K Pastey; Z Huang; S K Khattar; P L Collins; S K Samal
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

7.  Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.

Authors:  A P Durbin; M H Skiadopoulos; J M McAuliffe; J M Riggs; S R Surman; P L Collins; B R Murphy
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates.

Authors:  Alexander Bukreyev; Zhuhui Huang; Lijuan Yang; Subbiah Elankumaran; Marisa St Claire; Brian R Murphy; Siba K Samal; Peter L Collins
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 9.  Avian pneumoviruses and emergence of a new type in the United States of America.

Authors:  B S Seal
Journal:  Anim Health Res Rev       Date:  2000-06       Impact factor: 2.615

10.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

Authors:  B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

View more
  12 in total

1.  Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain.

Authors:  Jing Sun; Yongwei Wei; Abdul Rauf; Yu Zhang; Yuanmei Ma; Xiaodong Zhang; Konstantin Shilo; Qingzhong Yu; Y M Saif; Xingmeng Lu; Lian Yu; Jianrong Li
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

2.  TMPRSS12 Is an Activating Protease for Subtype B Avian Metapneumovirus.

Authors:  Bingling Yun; Yao Zhang; Yongzhen Liu; Xiaolu Guan; Yongqiang Wang; Xiaole Qi; Hongyu Cui; Changjun Liu; Yanping Zhang; Honglei Gao; Li Gao; Kai Li; Yulong Gao; Xiaomei Wang
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

3.  The conserved YAGL motif in human metapneumovirus is required for higher-order cellular assemblies of the matrix protein and for virion production.

Authors:  Yosef Sabo; Marcelo Ehrlich; Eran Bacharach
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

4.  Molecular characterization of circulating avian metapneumovirus, subgroup B, in broiler chickens, Iran, 2016-2018.

Authors:  H Hosseini; Z Ziafati Kafi; M Malekan; S A Ghafouri; M H Fallah Mehrabadi; N Sadri; A Hojabr Rajeoni; A Ghalyanchilangeroudi
Journal:  Iran J Vet Res       Date:  2021       Impact factor: 1.376

5.  Localization of a region in the fusion protein of avian metapneumovirus that modulates cell-cell fusion.

Authors:  Yongwei Wei; Kurtis Feng; Xiangjie Yao; Hui Cai; Junan Li; Anne M Mirza; Ronald M Iorio; Jianrong Li
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

6.  Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase.

Authors:  Yu Zhang; Yongwei Wei; Xiaodong Zhang; Hui Cai; Stefan Niewiesk; Jianrong Li
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

7.  Roles of the putative integrin-binding motif of the human metapneumovirus fusion (f) protein in cell-cell fusion, viral infectivity, and pathogenesis.

Authors:  Yongwei Wei; Yu Zhang; Hui Cai; Anne M Mirza; Ronald M Iorio; Mark E Peeples; Stefan Niewiesk; Jianrong Li
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

Review 8.  Paramyxovirus fusion and entry: multiple paths to a common end.

Authors:  Andres Chang; Rebecca E Dutch
Journal:  Viruses       Date:  2012-04-19       Impact factor: 5.048

9.  Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine.

Authors:  Satya Parida; Madhuchhanda Mahapatra; Sai Kumar; Subash C Das; Michael D Baron; John Anderson; Thomas Barrett
Journal:  J Gen Virol       Date:  2007-07       Impact factor: 3.891

Review 10.  Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production.

Authors:  Farah El Najjar; Anthony P Schmitt; Rebecca Ellis Dutch
Journal:  Viruses       Date:  2014-08-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.